+Search query
-Structure paper
Title | Potent cross-reactive mAbs from BA.4/5 breakthrough infection |
---|---|
Journal, issue, pages | To Be Published |
Publish date | Feb 9, 2023 (structure data deposition date) |
Authors | Duyvesteyn HME / Screaton G / Ren J / Stuart DI / Fry EE |
External links | Search PubMed |
Methods | EM (single particle) / X-ray diffraction |
Resolution | 2.33 - 3.52 Å |
Structure data | EMDB-16676, PDB-8cii: EMDB-16680: BA.4/5-5 FAB IN COMPLEX WITH SARS-COV-2 BA.4 SPIKE GLYCOPROTEIN PDB-8cbd: PDB-8cbe: PDB-8cbf: PDB-8cma: |
Chemicals | ChemComp-NAG: ChemComp-GOL: ChemComp-SO4: ChemComp-CL: ChemComp-HOH: |
Source |
|
Keywords | VIRAL PROTEIN / SARS-CoV-2 / BA.4 mAb / BA.5 mAb / RBD / BA.4/5-1 / BA.4/5-2 / BA.4/5-5 / EY6A / VIRAL PROTEIN/Immune system / Beta-49 / Omi-42 / VIRUS / SARS-CoV2 / spike / glycoprotein / cornovavirus / antibody / fab / BA.4 / BA.5 / BA.2 / Delta variant / cross-protective / omicron variant / vaccine / therapeutic / complex / neutralising / convalescent sera / immune system / C1 nanobody / SARS1-34 fab / BA.2-07 fab / BA.4/5-35 |